Numerous studies have documented a large discrepancy between prescribed and delivered dose of therapy either with intermittent hemodialysis 3 or with continuous renal replacement therapy (CRRT). 4 ...

To provide medical professionals (RN, MD, Pharmacist) with the knowledge and understanding for decision making for the effective utilization of Continuous Renal Replacement Therapy (CRRT ... inferior ...

In older ESRD patients on renal replacement therapy (RRT) with frailty phenotype, the risk of mortality at 1 year is three-times higher compared with ESRD patients without frailty phenotype.

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

Although few Asian countries have renal replacement therapy (RRT) registries ... the standards of developed nations in the next two to three decades, and the challenge of RRT can be met only ...

Some clinical trials have validated a new perspective on continuous renal replacement therapy (CRRT) in combination with oXiris haemofilter to more effectively enhance endotoxins clearance and ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...

continuous renal replacement therapies, kidney biopsies, and plasmapheresis for infants, children and adolescents. In order to maximize health and quality of life, the renal care center is one of ...